Diebold Nixdorf, Incorporated

Fundamentals8.0
Price Action6.0
News Sentiment6.0
AI Rating
6.0

Key Drivers

  • Strong FCF
  • Modest margins
  • Manageable leverage

AI
AI Summary

6.0

DBD has shifted from a turnaround gamble to an execution-driven cash generator—buybacks and doubled FCF make it worth owning for investors focused on cash returns, but this thesis is contingent: specifically monitor FCF conversion against DSO/DIO and whether orders (+17%) reliably convert to sequential revenue (and not just backlog) while service-margin drag is absorbed. If FCF keeps expanding and the stock reclaims/holds >$80, the thesis strengthens; if revenue conversion or service margins worsen, prepare for rapid repricing.

CashFlow
ExecutionRisk
OrderConversion‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

8.0

Key Financial Insights:

  • Strong FCF
  • Modest margins
  • Manageable leverage

DBD generates strong free cash flow and manageable leverage but has modest margins, working-cap intensity and a premium valuation that elevate risk if margins or cash stability weaken.

CashGeneration
ValuationRisk

Price Behavior

6.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Steep month decline
  • Below short-term MA
  • Support testing now

Over the last month the stock dropped about 12% from $81.24 to $71.45, trading ~7% below its last-month SMA (~$76.90), signaling a clear short-term downtrend with support at $71.45 and resistance near $80–$83.

Bearish
Watch
Support Level: $71.45
Resistance Level: $80–$83

~12% fall from $81.24 to $71.45 over last month, trading ~7% below last-month

Sentiment & News

6.0

Key News Insights:

  • Leadership hire
  • International rollout
  • Award recognition

Diebold Nixdorf drew investor attention in March 2026 after a strategic product/tech leadership hire, international DN Series deployments and industry awards, but shares lagged amid heightened analyst scrutiny and short-term price weakness.

Momentum
Volatility

Positive product and leadership developments support long-term fundamentals, but near-term analyst scrutiny and recent share weakness may keep the stock volatile